Secondary prevention study of coronary heart disease in aged patients using Xuezhikang
- VernacularTitle:血脂康对老年人冠心病二级预防的作用
- Author:
Zong LU
- Publication Type:Journal Article
- Keywords:
Coronary disease;
Prevention health services;
Xuezhikang
- From:
Chinese Journal of Geriatrics
2003;0(11):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate whether lipid-lowering therapy with Xuezhikang can reduce the risk of cardiac events and total mortality in aged coronary heart disease(CHD) patients. Methods 2550 aged and 2320 non-aged patients were selected and given with capsule Xuezhikang 0.6 g bid or placebo in addition to conventional therapy.The mean follow-up period was four years. Results The incidence of CHD events and the total mortality of aged patients were significantly higher than the non-aged.The incidence of CHD events was reduced by 41.3% for treatment group(P
